Advertisement

Sporadic and NF2-associated vestibular schwannoma surgery and simultaneous cochlear implantation: a comparative systematic review

  • Niels WestEmail author
  • Hjalte Sass
  • Per Cayé-Thomasen
Review Article
  • 2 Downloads

Abstract

Purpose

Cochlear implantation (CI) in patients with sensorineural hearing loss caused by a vestibular schwannoma (VS) represents a unique subtype of hearing rehabilitation, as the outcome may be compromised by vestibulocochlear nerve injury as part of the natural VS history or due to iatrogenic trauma induced by surgical tumor removal. This paper aims to review and report contemporary knowledge and practice regarding feasibility and outcomes of simultaneous vestibular schwannoma resection and cochlear implantation to serve as a reference and guide for future surgery and studies.

Methods

The current literature was searched systematically according to the PRISMA guidelines and after criteria-based selection, 29 studies were identified, including a total of 86 patients who had undergone surgical resection of a vestibular schwannoma and subsequent cochlear implantation in a single procedure.

Results

The postoperative outcomes were reported with a high degree of heterogeneity, hindering a proper meta-analysis. However, pooling those cases with reported speech discrimination outcomes demonstrated mean scores equivalent to moderate-to-high performance. A few cases had no audibility. A positive cochlear nerve test result was not a secure positive predictor of success. Complications were rare.

Conclusion

NF2-associated and sporadic VS had good and comparable postoperative outcomes despite significant differences in tumor size, location and surgical approach.

Keywords

Cochlear implant Acoustic neuroma Neurofibromatosis type 2 Treatment Hearing rehabilitation Hearing loss 

Notes

Funding

Nothing to disclose.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

N/A. This article does not contain any studies with human participants or animals performed by any of the authors.

Supplementary material

405_2019_5741_MOESM1_ESM.pdf (75 kb)
Supplementary file1 (PDF 75 kb)

References

  1. 1.
    Stangerup SE, Caye-Thomasen P (2012) Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin N Am 45(2):257–268CrossRefGoogle Scholar
  2. 2.
    Evans DGR, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R (2005) Incidence of vestibular schwannoma and neurofibromatosis 2 in the north west of England over a 10-year period: higher incidence than previously thought. Otol Neurotol 26(1):93–97PubMedCrossRefGoogle Scholar
  3. 3.
    West N, Møller MN, Hansen S, Cayé-Thomasen P (2018) Audiovestibular loss of function correlates in vestibular schwannomas. J Int Adv Otol 14(2):161–165PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Lloyd SKW, King AT, Rutherford SA, Hammerbeck-Ward CL, Freeman SRM, Mawman DJ et al (2017) Hearing optimisation in neurofibromatosis type 2: A systematic review. Clin Otolaryngol. 42(6):1329–1337PubMedCrossRefGoogle Scholar
  5. 5.
    Lassaletta L, Aristegui M, Medina M, Aranguez G, Pérez-Mora RM, Falcioni M et al (2016) Ipsilateral cochlear implantation in patients with sporadic vestibular schwannoma in the only or best hearing ear and in patients with NF2. Eur Arch Oto-Rhino-Laryngol 273(1):27–35CrossRefGoogle Scholar
  6. 6.
    Neff BA, Wiet RM, Lasak JM, Cohen NL, Pillsbury HC, Ramsden RT et al (2007) Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up. Laryngoscope 117(6):1069–1072PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Di Lella F, Merkus P, Di Trapani G, Taibah A, Guida M, Sanna M (2013) Vestibular schwannoma in the only hearing ear: role of cochlear implants. Ann Otol Rhinol Laryngol 122(2):91–99PubMedCrossRefGoogle Scholar
  8. 8.
    Hassepass F, Arndt S, Aschendorff A, Laszig R, Wesarg T (2016) Cochlear implantation for hearing rehabilitation in single-sided deafness after translabyrinthine vestibular schwannoma surgery. Eur Arch Oto-Rhino-Laryngol 273(9):2373–2383CrossRefGoogle Scholar
  9. 9.
    Arriaga MA, Marks S (1995) Simultaneous cochlear implantation and acoustic neuroma resection: imaging considerations, technique, and functional outcome. Otolaryngol Head Neck Surg 112(2):325–328PubMedCrossRefGoogle Scholar
  10. 10.
    Moher D, Liberati A, Tetzlaff J, Altman DG (2010) Preferred reporting items for systematic reviews and meta-analyses: yhe PRISMA statement. Int J Surg 8(5):336–341PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at https://www.covidence.org. Accessed 16 Oct 2018
  12. 12.
    Kanzaki J, Tos M, Sanna M, Moffat Da, Monsell EM, Berliner KI. New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma. Otol Neurotol. 2003;24(4):642–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Monsell EM, Balkany TA, Gates GA, Goldenberg RA, William LM, House JW (1995) Committee on hearing and equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). Otolaryngol-Head Neck Surg. 113(3):179–180CrossRefGoogle Scholar
  14. 14.
    Clark JG (1981) Uses and abuses of hearing loss classification. J Am Speech-Language-Hear Assoc 23(January):493–500Google Scholar
  15. 15.
    Ahsan S, Telischi F, Hodges A, Balkany T (2003) Cochlear implantation concurrent with translabyrinthine acoustic neuroma resection. Laryngoscope 113(3):472–474PubMedCrossRefGoogle Scholar
  16. 16.
    Cruz OLM, Vellutini EAS (2011) Cochlear implant in type 2 neurofibromatosis: an option for better hearing rehabilitation. Braz J Otorhinolaryngol 77(4):538PubMedCrossRefGoogle Scholar
  17. 17.
    Bento RF, Gebrim EMMS, Magalhães ATDM, Pereira LV, Fonseca ACDO (2016) Minimally invasive surgery for intracochlear schwannoma removal and simultaneous cochlear implantation. Int Arch Otorhinolaryngol 20(3):271–274PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Schutt CA, Kveton JF (2014) Cochlear implantation after resection of an intralabyrinthine schwannoma. Am J Otolaryngol - Head Neck Med Surg 35(2):257–260Google Scholar
  19. 19.
    Arístegui M, Denia A (2005) Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in an only hearing ear: Report of two cases (neurofibromatosis type 2 and unilateral vestibular schwannoma). Otol Neurotol 26(2):205–210PubMedCrossRefGoogle Scholar
  20. 20.
    Bento RF, Monteiro TA, Bittencourt AG, Goffi-Gomez MVS, De Brito R (2013) Retrolabyrinthine approach for cochlear nerve preservation in neurofibromatosis type 2 and simultaneous cochlear implantation. Int Arch Otorhinolaryngol 17(3):351–355PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    DeHart AN, Broaddus WC, Coelho DH (2017) Translabyrinthine vestibular schwannoma resection with simultaneous cochlear implantation. Cochlear Implants Int 18(5):278–284PubMedCrossRefGoogle Scholar
  22. 22.
    Kim JW, Han JH, Kim JW, Moon IS (2016) Simultaneous translabyrinthine tumor removal and cochlear implantation in vestibular schwannoma patients. Yonsei Med J 57(6):1535–1539PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Rooth MA, Dillon MT, Brown KD (2017) Prospective evaluation of patients undergoing translabyrinthine excision of vestibular schwannoma with concurrent cochlear implantation. Otol Neurotol 38(10):1512–1516PubMedCrossRefGoogle Scholar
  24. 24.
    Sanna M, Del Mar MM, Macak A, Rossi G, Sozzi V, Prasad SC (2017) Vestibular schwannoma resection with ipsilateral simultaneous cochlear implantation in patients with normal contralateral hearing. Audiol Neurotol 21(5):286–295CrossRefGoogle Scholar
  25. 25.
    Zanetti D, Campovecchi CB, Pasini S, Nassif N (2008) Simultaneous translabyrinthine removal of acoustic neuroma and cochlear implantation. Auris Nasus Larynx 35(4):562–568PubMedCrossRefGoogle Scholar
  26. 26.
    dos Santos Neto PH, Zamponi JO, Hamerschmidt R, Wiemes GRM, Rassi MS, Borba LAB (2018) Simultaneous cochlear implantation as a therapeutic option in vestibular schwannoma surgery: case report. Neurosurg Focus 44(3):E9PubMedCrossRefGoogle Scholar
  27. 27.
    Lloyd SKW, Glynn F, Rutherford SA, King AT, Mawman DJ, O’Driscoll MP et al (2013) Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2. Otol Neurotol 35:43–51CrossRefGoogle Scholar
  28. 28.
    Tran Ba Huy P, Kania R, Frachet B, Poncet C, Legac MS (2009) Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2. Acta Otolaryngol. 129(9):971–975PubMedCrossRefGoogle Scholar
  29. 29.
    Aschendorff A, Arndt S, Laszig R, Wesarg T, Hassepaß F, Beck R (2017) Therapie und Hörrehabilitation intralabyrinthärer schwannome mittels cochlear implant: englische version. HNO 65(1):46–51PubMedCrossRefGoogle Scholar
  30. 30.
    Plontke SK, Kösling S, Rahne T (2018) Cochlear implantation after partial or subtotal cochleoectomy for intracochlear schwannoma removal—a technical report. Otol Neurotol 39(3):365–371PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Plontke SK, Rahne T, Pfister M, Götze G, Heider C, Pazaitis N et al (2017) Intralabyrinthine schwannomas: surgical management and hearing rehabilitation with cochlear implants. HNO 65(5):419–433PubMedCrossRefGoogle Scholar
  32. 32.
    Van Abel KM, Carlson ML, Link MJ, Neff BA, Beatty CW, Lohse CM et al (2013) Primary inner ear schwannomas: a case series and systematic review of the literature. Laryngoscope 123(8):1957–1966PubMedCrossRefGoogle Scholar
  33. 33.
    Odat HA, Piccirillo E, Sequino G, Taibah A, Sanna M (2011) Management strategy of vestibular schwannoma in neurofibromatosis type 2. Otol Neurotol 32(7):1163–1170PubMedCrossRefGoogle Scholar
  34. 34.
    Carlson ML, Breen JT, Driscoll CL, Link MJ, Neff BA, Gifford RH et al (2012) Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance. Otol Neurotol 33(5):853–862PubMedCrossRefGoogle Scholar
  35. 35.
    North HJD, Mawman D, O’Driscoll M, Freeman SR, Rutherford SA, King AT et al (2016) Outcomes of cochlear implantation in patients with neurofibromatosis type 2. Cochlear Implants Int 17(4):172–177PubMedCrossRefGoogle Scholar
  36. 36.
    Tan H, Jia H, Li Y, Zhang Z, Zhu W, Cai Y et al (2018) Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2. Eur Arch Oto-Rhino-Laryngology. 275(11):2667–2674CrossRefGoogle Scholar
  37. 37.
    Vincenti V, Pasanisi E, Guida M, Di Trapani G, Sanna M (2008) Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation. Audiol Neurotol 13(4):273–280CrossRefGoogle Scholar
  38. 38.
    Kompis M, Pfiffner F, Cavesaccio M (2011) Factors influencing the decision for Baha in unilateral deafness: the Bern benefit in single sided deafness questionnaire. 10th European Federation of Audiology Societies (EFAS) Congress. J Hear Sci. 1(1):96Google Scholar
  39. 39.
    Wazen JJ, Spitzer JB, Ghossaini SN, Fayad JN, Niparko JK, Cox K et al (2003) Transcranial contralateral cochlear stimulation in unilateral deafness. Otolaryngol - Head Neck Surg 129(3):248–254PubMedCrossRefGoogle Scholar
  40. 40.
    Noble W, Jensen NS, Naylor G, Bhullar N, Akeroyd MA (2013) A short form of the speech, spatial and qualities of hearing scale suitable for clinical use: the SSQ12. Int J Audiol 52(6):409–412PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Harris F, Tysome JR, Donnelly N, Durie-Gair J, Crundwell G, Tam YC et al (2017) Cochlear implants in the management of hearing loss in neurofibromatosis type 2. Cochlear Implants Int 18(3):171–179PubMedCrossRefGoogle Scholar
  42. 42.
    Peng KA, Lorenz MB, Otto SR, Brackmann DE, Wilkinson EP (2018) Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2. Laryngoscope 128(9):2163–2169PubMedCrossRefGoogle Scholar
  43. 43.
    Özdek A, Bayir Ö, Dönmez T, Özişik P, Şahin M, Tulgar M et al (2014) Hearing restoration in NF2 patients and patients with vestibular schwannoma in the only hearing ear: report of two cases. Am J Otolaryngol - Head Neck Med Surg 35(4):538–541Google Scholar
  44. 44.
    Helbig S, Rader T, Bahmer A, Baumann U (2009) A case of bilateral cochlear implantation in single-sided untreated acoustic neurinoma. Acta Otolaryngol 129(6):694–696PubMedCrossRefGoogle Scholar
  45. 45.
    Trotter MI, Briggs RJS (2010) Cochlear implantation in neurofibromatosis type 2 after radiation therapy. Otol Neurotol 31(2):216–219PubMedCrossRefGoogle Scholar
  46. 46.
    Miyazaki H, Cayé-Thomasen P (2018) Intraoperative auditory system monitoring. Adv Otorhinolaryngol 81:123–132PubMedGoogle Scholar
  47. 47.
    Caye-Thomasen P, Dam MS, Omland SH, Mantoni M (2012) Cochlear ossification in patients with profound hearing loss following bacterial meningitis. Acta Otolaryngol 132(7):720–725PubMedCrossRefGoogle Scholar
  48. 48.
    West N, Sass H, Møller MN, Caye-Thomasen P (2019) Cochlear MRI signal change following vestibular schwannoma resection depends on surgical approach. Otol Neurotol. 40(10):e999–1005PubMedCrossRefGoogle Scholar
  49. 49.
    Belal A (2001) Is cochlear implantation possible after acoustic tumor removal? Otol Neurotol 22(4):497–500PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Otorhinolaryngology Head and Neck Surgery and Audiology, RigshospitaletUniversity Hospital of CopenhagenCopenhagenDenmark
  2. 2.Faculty of Health and Medical SciencesUniversity of CopenhagenCopenhagenDenmark

Personalised recommendations